GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical (TADAWUL:)…
Tag: Enter
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
— Strategic Partnership Strengthens Gilead’s Inflammation Research Portfolio with the Addition of LEO Pharma’s Preclinical Oral…
FIGS: Enter A White Knight? (NYSE:FIGS)
This article was written by Follow Author of the Macro Trends & Inflection Points Newsletter. I…